Skip to main content
. 2021 Oct 25;2021(10):CD012612. doi: 10.1002/14651858.CD012612.pub2

English 2015.

Study characteristics
Methods RCT
Participants were recruited into the study, and randomised into 1 of 3 treatment arms
Assessment
Intervention
Postintervention and follow‐up assessment
Participants 283 participants in 3 study groups (only 2 study groups met the criteria for this Cochrane Review)
Usual care (5 day): n = 94; mean age 68.2 years; 52 males; 28.7 days between stroke and randomisation
7‐day therapy: n = 96; mean age 71.9 years; 59 males; 25.0 days between stroke and randomisation 
All participants were 5–197 days poststroke on entry to the study
Inpatient setting in Australia
Interventions 7‐day therapy: therapy provided 7 days per week for a maximum of 90 minutes per day (maximum of 630 minutes per week)
Usual care (5‐day therapy): therapy provided 5 days per week for a maximum of 90 minutes per day (maximum of 450 minutes per week)
Intervention was provided over 4 weeks
Outcomes FIM
WMFT
6‐minute walk test
Walking speed
Functional Ambulation Classification
SIS physical subscale
Length of stay
AQoL Scale
Adverse events
Assessed at baseline, 4 weeks, 3 months and 6 months postrandomisation (SIS and the AQoL no baseline)
Notes Study controlled for the number of minutes of rehabilitation provided each week and the frequency of rehabilitation intervention
Conflict of Interests: none
Funding:  supported by a National Health and Medical Research Project Council Grant #631904